The treatment result must primarily have value for the patient
Patients ask what the prospects are for treatment success and the highest possible quality of life in proportion to the stress, side effects, and aftereffects. The treatment team wants to know which therapy decision is the best for this patient. The pharmaceutical and medtech industries are challenged with the task of securing the treatment result: can the desired treatment success be achieved with the therapy approaches? Ultimately, the health insurance company asks if the expected benefit is appropriately related to the costs of treatment and medication.
All the players strive to do everything right, but ultimately the treatment outcome must primarily have value for the patient. If so, the costs are automatically reduced over time. That is the basic idea behind value-based healthcare.
Not more performance—but more responsibility
What is needed is not more performance but more responsibility for the desired treatment outcome and the resources used to achieve it—across all treatments and over time.
What contribution can the healthcare institution make? Start by creating a solid basis for measuring treatment outcomes. Continuously collect, analyze, and reflect on treatment outcomes and quality indicators. Network with international peers. Learn from each other and thereby advance patient-centered, cutting-edge medicine.
Create the right culture
Implementation of a value-based healthcare approach is challenging. It requires considerable willingness to change on the part of both the patient and the medical staff. The commitment of all those involved is central. Fragmented stored clinical data must be brought together to form a whole. Evaluations and visualizations at the push of a button do not come automatically and certainly not for free.
Many questions, both conceptual and practical, are still unresolved. The indication must be measured as accurately as the treatment result. Not everything that can be measured makes sense. Not everything that makes sense is measurable. Risk adjustment must be considered just as much as the complexity of a treated patient population. In-house, regional, national, and international benchmarking together with peer review should be well organized. A culture is needed that promotes mutual learning with the goal of long-term affordable patient-oriented quality.
Such a culture is worthwhile. Comparisons between different treatment programs benefit patients. Doctors who are committed to this direction regard it as an intellectual challenge. It drives them to be measured and compared with colleagues and other institutions on the basis of the treatment results they have achieved and had confirmed by patients.
Our offerings
«First-mover» project
For 6–9 months, we develop and bring to life value-based healthcare pilot solutions with you, both conceptually and practically and always with the goal of achieving a treatment result that primarily has value for the patient.
Rollout
After the initial pilot phase, it is important to maintain the first mover project’s dynamics and let the spark ignite other disciplines. We support you in firmly anchoring the value-based healthcare philosophy throughout the organization.
Do you want to learn more?
Would you like to learn more about value-based healthcare? We would be delighted to tell you more about our project work in an obligation-free conversation or answer any questions you may have. Our team is looking forward to hearing from you!